For: |
Cucchetti A, Piscaglia F, Cescon M, Ercolani G, Pinna AD. Systematic review of surgical resection |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i26/4106.htm |
Number | Citing Articles |
1 |
Karen T. Brown, Anne M. Covey. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 525 doi: 10.1016/B978-0-323-34062-5.00030-3
|
2 |
Masatoshi SHOJI, Hiroyuki TAKAMURA, Hironori HAYASHI, Shin-ichi NAKANUMA, Hirohisa KITAGAWA, Tetsuo OHTA. A Case of Recurrent Intraphepatic Cholangicarcinoma with Sarcomatous Change after Repeated Local Therapies. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2014; 75(7): 2001 doi: 10.3919/jjsa.75.2001
|
3 |
Takeshi Terashima, Yoichi Higashibeppu, Tatsuya Yamashita, Yukinori Sakata, Mie Azuma, Hiroaki Munakata, Mika Ishii, Shuichi Kaneko. Comparative analysis of medical costs after hepatectomy versus radiofrequency ablation in patients with hepatocellular carcinoma in real‐world clinical practice. Hepatology Research 2022; 52(5): 471 doi: 10.1111/hepr.13756
|
4 |
A Cucchetti, V Mazzaferro, A D Pinna, C Sposito, R Golfieri, C Serra, C Spreafico, F Piscaglia, A Cappelli, M Bongini, M Cucchi, M Cescon. Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma. British Journal of Surgery 2017; 104(12): 1704 doi: 10.1002/bjs.10613
|
5 |
Marc Bourlière, Stanislas Pol. Abstracts. Liver International 2019; 39(12): 2420 doi: 10.1111/liv.14255
|
6 |
C. R. Wong, B. Njei, M. H. Nguyen, A. Nguyen, J. K. Lim. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2017; 46(11-12): 1061 doi: 10.1111/apt.14342
|
7 |
Stefania Brozzetti, Simone Bini, Chiara D’Alterio, Chiara De Lucia, Leonardo Luca Chiarella, Katia Fazzi, Michele Di Martino. Liver Disease and Surgery [Working Title]. 2019; doi: 10.5772/intechopen.86638
|
8 |
Lisa P Waller, Vrushak Deshpande, Nikolaos Pyrsopoulos. Hepatocellular carcinoma: A comprehensive review. World Journal of Hepatology 2015; 7(26): 2648-2663 doi: 10.4254/wjh.v7.i26.2648
|
9 |
Mohamed Mourad, Jean-Yves Mabrut, Madiha Chellakhi, Mickaël Lesurtel, Célia Prevost, Christian Ducerf, Agnès Rode, Philippe Merle, Françoise Mornex, Kayvan Mohkam. Neoadjuvant Conformal Radiotherapy Before Liver Transplantation for Hepatocellular Carcinoma: A Propensity Score Matched Analysis of Postoperative Morbidity and Oncological Results. Future Oncology 2019; 15(21): 2517 doi: 10.2217/fon-2019-0127
|
10 |
Gonzalo Sapisochin, Elena Fernandez de Sevilla, Juan Echeverri, Ramón Charco. Management of “very early” hepatocellular carcinoma on cirrhotic patients. World Journal of Hepatology 2014; 6(11): 766-775 doi: 10.4254/wjh.v6.i11.766
|
11 |
Samantha M. Ruff, Adam Khader, Charles Conte, Alan Kadison, James Sullivan, John Wang, Raza Zaidi, Gary B. Deutsch. Improved outcomes with surgery compared to radiofrequency ablation in the treatment of resectable hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 2019; 31(11): 1397 doi: 10.1097/MEG.0000000000001416
|
12 |
Zhao-Shan Niu, Xiao-Jun Niu, Mei Wang. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival. World Journal of Hepatology 2015; 7(1): 7-27 doi: 10.4254/wjh.v7.i1.7
|
13 |
Konrad Mohnike, Ingo G. Steffen, Max Seidensticker, Peter Hass, Robert Damm, Nils Peters, Ricarda Seidensticker, Kerstin Schütte, Jörg Arend, Jan Bornschein, Tina Streitparth, Christian Wybranski, Gero Wieners, Patrick Stübs, Peter Malfertheiner, Maciej Pech, Jens Ricke. Radioablation by Image-Guided (HDR) Brachytherapy and Transarterial Chemoembolization in Hepatocellular Carcinoma: A Randomized Phase II Trial. CardioVascular and Interventional Radiology 2019; 42(2): 239 doi: 10.1007/s00270-018-2127-5
|
14 |
Yasunobu Matsuda, Toshifumi Wakai, Yuki Hirose, Mami Osawa, Shun Fujimaki, Masayuki Kubota. p27 Is a Critical Prognostic Biomarker in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma. International Journal of Molecular Sciences 2013; 14(12): 23499 doi: 10.3390/ijms141223499
|
15 |
Shengyong Yin, Xudong Miao, Xueming Zhang, Xinhua Chen, Hao Wen. Environmental temperature affects physiology and survival of nanosecond pulsed electric field‐treated cells. Journal of Cellular Physiology 2018; 233(2): 1179 doi: 10.1002/jcp.25984
|
16 |
Masashi Mizumoto, Yoshiko Oshiro, Toshiyuki Okumura, Kuniaki Fukuda, Nobuyoshi Fukumitsu, Masato Abei, Hitoshi Ishikawa, Kayoko Ohnishi, Haruko Numajiri, Koji Tsuboi, Hideyuki Sakurai. Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapy. Radiotherapy and Oncology 2014; 113(1): 54 doi: 10.1016/j.radonc.2014.08.015
|
17 |
Arnaud Hocquelet, Pierre Balageas, Christophe Laurent, Jean-Frédéric Blanc, Nora Frulio, Cécile Salut, Christophe Cassinotto, Jean Saric, Laurent Possenti, Pierre-Henri Bernard, Michel Montaudon, Hervé Trillaud. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients. International Journal of Hyperthermia 2015; 31(7): 749 doi: 10.3109/02656736.2015.1068382
|
18 |
N. Scher, G. Janoray, F.-G. Riet, A.-G. Le Bayon, K. Debbi, S. Lévy, P. Louisot, P. Garaud, E. Chajon, I. Barillot, É. Salamé, R. de Crevoisier, S. Chapet, G. Calais. Radiothérapie en conditions stéréotaxiques du carcinome hépatocellulaire : résultats d’une étude rétrospective multicentrique. Cancer/Radiothérapie 2019; 23(2): 104 doi: 10.1016/j.canrad.2018.07.138
|
19 |
Kevin Ka Wan Chu, Tan To Cheung. Update in management of hepatocellular carcinoma in Eastern population. World Journal of Hepatology 2015; 7(11): 1562-1571 doi: 10.4254/wjh.v7.i11.1562
|
20 |
Alessandro Granito, Luigi Bolondi. Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis. The Lancet Oncology 2017; 18(2): e101 doi: 10.1016/S1470-2045(16)30569-1
|
21 |
T. Hofmockel, V. Plodeck, M. Laniado, R.-T. Hoffmann. Thermoablative Therapie des hepatozellulären Karzinoms. Der Radiologe 2014; 54(7): 679 doi: 10.1007/s00117-014-2654-2
|
22 |
Xiangzhong Huang, Xinjian Xu, Hongtao Du, Qiulian Sun, Minyu Wu. Meta-analysis of cryoablation versus radiofrequency ablation in the treatment of malignant liver tumors. International Journal of Hyperthermia 2024; 41(1) doi: 10.1080/02656736.2023.2300347
|
23 |
Akiko Ishigami, Shogo Inaka, Yuko Ishida, Mizuho Nosaka, Yumi Kuninaka, Hiroki Yamamoto, Emi Shimada, Akihiko Kimura, Fukumi Furukawa, Toshikazu Kondo. A case of hemoperitoneum after percutaneous radiofrequency ablation in a patient with hepatocellular carcinoma. Forensic Science, Medicine and Pathology 2023; 20(1): 189 doi: 10.1007/s12024-023-00601-w
|
24 |
Gaeun Kim, Soon Koo Baik. Overview and recent trends of systematic reviews and meta-analyses in hepatology. Clinical and Molecular Hepatology 2014; 20(2): 137 doi: 10.3350/cmh.2014.20.2.137
|
25 |
CHAOHUI ZUO, MAN XIA, QUNFENG WU, HAIZHEN ZHU, JINGSHI LIU, CHEN LIU. Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review). Oncology Letters 2015; 9(2): 527 doi: 10.3892/ol.2014.2727
|
26 |
Wan Yee Lau, Stephanie Hiu Yan Lau. The current role of radiofrequency ablation in the treatment of hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2017; 16(2): 122 doi: 10.1016/S1499-3872(16)60182-0
|
27 |
Dong-Sheng Sun, Cang-Hai Guan, Wei-Na Wang, Zeng-Tao Hu, Yu-Qiao Zhao, Xing-Ming Jiang. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis. Microvascular Research 2021; 134: 104120 doi: 10.1016/j.mvr.2020.104120
|
28 |
Kazuki Murai, Akira Yamamoto, Ken Kageyama, Mariko Nakano, Atsushi Jogo, Yukio Miki. A case of recurrent laryngeal nerve paralysis caused by radiofrequency ablation for mediastinal recurrence of lung cancer. Radiology Case Reports 2024; 19(4): 1397 doi: 10.1016/j.radcr.2023.12.059
|
29 |
Hla‐Hla Thein, Wanrudee Isaranuwatchai, Yao Qiao, Kenny Wong, Gonzalo Sapisochin, Kelvin K. W. Chan, Eric M. Yoshida, Craig C. Earle. Cost‐effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person‐level data in a Canadian setting. Cancer Medicine 2017; 6(9): 2017 doi: 10.1002/cam4.1119
|
30 |
Antonio Facciorusso, Michele Barone. Hepatocellular Carcinoma. 2016; : 453 doi: 10.1007/978-3-319-34214-6_30
|
31 |
Moon Haeng Hur, Jeong-Hoon Lee, Ju Yeon Kim, Ji Hoon Hong, Min Kyung Park, Hee Jin Cho, Na Ryung Choi, Jihye Kim, Minseok Albert Kim, Joon Yeul Nam, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Dong Ho Lee, Jeong Min Lee, Suk Kyun Hong, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Jung-Hwan Yoon. Comparison of Overall Survival between Surgical Resection and Radiofrequency Ablation for Hepatitis B-Related Hepatocellular Carcinoma. Cancers 2021; 13(23): 6009 doi: 10.3390/cancers13236009
|
32 |
Jeffrey S. Wicks, Benjamin S. Dale, Luis Ruffolo, Ludia J. Pack, Richard Dunne, Marie A. Laryea, Roberto Hernandez-Alejandro, Ashwani Kumar Sharma. Comparable and Complimentary Modalities for Treatment of Small-Sized HCC: Surgical Resection, Radiofrequency Ablation, and Microwave Ablation. Journal of Clinical Medicine 2023; 12(15): 5006 doi: 10.3390/jcm12155006
|
33 |
Darren W. Chua, Ye-Xin Koh, Nicholas L. Syn, Tan Yu Chuan, Teo Jin Yao, Ser-Yee Lee, Brian K. P. Goh, Peng-Chung Cheow, Alexander Y. Chung, Chung-Yip Chan. Repeat hepatectomy versus radiofrequency ablation in management of recurrent hepatocellular carcinoma: an average treatment effect analysis. Annals of Surgical Oncology 2021; 28(12): 7731 doi: 10.1245/s10434-021-09948-2
|
34 |
Gianni Testino, Silvia Leone, Paolo Borro. Alcohol and hepatocellular carcinoma: A review and a point of view. World Journal of Gastroenterology 2014; 20(43): 15943-15954 doi: 10.3748/wjg.v20.i43.15943
|
35 |
Shoujin Cao, Yinghua Zou, Tianshi Lyu, Zeyang Fan, Haitao Guan, Li Song, Xiaoqiang Tong, Jian Wang. Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progression. International Journal of Hyperthermia 2022; 39(1): 1 doi: 10.1080/02656736.2021.1998660
|
36 |
Gaya Spolverato, Alessandro Vitale, Aslam Ejaz, Yuhree Kim, Shishir K. Maithel, David P. Cosgrove, Timothy M. Pawlik. The Relative Net Health Benefit of Liver Resection, Ablation, and Transplantation for Early Hepatocellular Carcinoma. World Journal of Surgery 2015; 39(6): 1474 doi: 10.1007/s00268-015-2987-7
|
37 |
Simon Chun Ho Yu, Joyce Wai Yi Hui, Charing Ching Ning Chong, Cheuk Man Chu, Sunny Cheung, John Wong, Kit Fai Lee. Transarterial Ethanol Ablation for Small Hepatocellular Carcinoma (≤ 3 cm): A Comparative Study Versus Radiofrequency Ablation. CardioVascular and Interventional Radiology 2020; 43(5): 732 doi: 10.1007/s00270-020-02426-4
|
38 |
Kevin N. Shah, Bryan M. Clary. Endoscopic and Percutaneous Approaches to the Treatment of Biliary Tract and Primary Liver Tumors. Surgical Oncology Clinics of North America 2014; 23(2): 207 doi: 10.1016/j.soc.2013.10.003
|
39 |
Hao Chen, Chun-Hui Yuan, Yi-Fei Yang, Chang-Qing Yin, Qing Guan, Fu-Bing Wang, Jian-Cheng Tu. Subtractive Cell-SELEX Selection of DNA Aptamers Binding Specifically and Selectively to Hepatocellular Carcinoma Cells with High Metastatic Potential. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/5735869
|
40 |
Davide Ippolito, Anna Pecorelli, Giulia Querques, Silvia Girolama Drago, Cesare Maino, Cammillo Talei Franzesi, Adam Hatzidakis, Sandro Sironi. Dynamic Computed Tomography Perfusion Imaging: Complementary Diagnostic Tool in Hepatocellular Carcinoma Assessment From Diagnosis to Treatment Follow-up. Academic Radiology 2019; 26(12): 1675 doi: 10.1016/j.acra.2019.02.010
|
41 |
Gelareh Sadigh, Nadine Abi-Jaoudeh. Surgery Versus Ablation for Small Hepatocellular Carcinoma Treatment and Role of Personalized Medicine. Journal of the American College of Radiology 2022; 19(11): 1224 doi: 10.1016/j.jacr.2022.09.023
|
42 |
Alessandro Cucchetti, Fabio Piscaglia, Matteo Cescon, Carla Serra, Antonio Colecchia, Lorenzo Maroni, Laura Venerandi, Giorgio Ercolani, Antonio Daniele Pinna. An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. Digestive and Liver Disease 2014; 46(3): 257 doi: 10.1016/j.dld.2013.10.015
|
43 |
Antonio Facciorusso, Gaetano Serviddio, Nicola Muscatiello. Local ablative treatments for hepatocellular carcinoma: An updated review. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(4): 477-489 doi: 10.4292/wjgpt.v7.i4.477
|
44 |
Hao-Wen Sim, Jennifer Knox, Laura A. Dawson. An Update on Randomized Clinical Trials in Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 2017; 26(4): 647 doi: 10.1016/j.soc.2017.05.006
|
45 |
Jia-yan Ni, Lin-feng Xu, Hong-liang Sun, Jing-xing Zhou, Yao-ting Chen, Jiang-hong Luo. Percutaneous ablation therapy versus surgical resection in the treatment for early-stage hepatocellular carcinoma: a meta-analysis of 21,494 patients. Journal of Cancer Research and Clinical Oncology 2013; 139(12): 2021 doi: 10.1007/s00432-013-1530-1
|
46 |
Danyang Chao, Lijun Pang, Ying Shi, Wenjing Wang, Kai Liu. AZD3759 induces apoptosis in hepatoma cells by activating a p53-SMAD4 positive feedback loop. Biochemical and Biophysical Research Communications 2019; 509(2): 535 doi: 10.1016/j.bbrc.2018.12.102
|
47 |
Alessandro Cucchetti, Omar Elshaarawy, Guohong Han, Charing C. N. Chong, Carla Serra, Joanne Marie O’Rourke, Richard Crew, Cristina Felicani, Giorgio Ercolani, Tahir Shah, Arndt Vogel, Paul B. S. Lai, Philip J. Johnson. ‘Potentially curative therapies’ for hepatocellular carcinoma: how many patients can actually be cured?. British Journal of Cancer 2023; 128(9): 1665 doi: 10.1038/s41416-023-02188-z
|
48 |
Resmi A. Charalel, Alvin I. Mushlin, Xinyan Zheng, Jialin Mao, Ruth C. Carlos, Robert S. Brown, Brett E. Fortune, Adam D. Talenfeld, David C. Madoff, Said Ibrahim, Matthew S. Johnson, Art Sedrakyan. Beyond Survival: Adverse Events and Care Delivery Outcomes after Early Liver Cancer Treatment in a Nationally Representative Cohort. Journal of Vascular and Interventional Radiology 2023; 34(11): 1997 doi: 10.1016/j.jvir.2023.07.010
|
49 |
Abigail Mills, David Thayer, Christopher Noda, Amber Salter, Yu Tao, Minzhi Xing, Robert Martin, Raja Ramaswamy, Olaguoke Akinwande. Thermal Ablation Versus Surgical Resection for Localized Hepatocellular Carcinoma: A Population Study Using the SEER Database. Future Oncology 2018; 14(7): 631 doi: 10.2217/fon-2017-0447
|
50 |
Yandong Wang, Xiang Jing, Jianmin Ding. Clinical value of dynamic 3-dimensional contrast-enhanced ultrasound imaging for the assessment of hepatocellular carcinoma ablation. Clinical Imaging 2016; 40(3): 402 doi: 10.1016/j.clinimag.2015.11.022
|
51 |
Qinghua Xu, Seijin Kobayashi, Xun Ye, Xia Meng. Comparison of Hepatic Resection and Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Meta-Analysis of 16,103 Patients. Scientific Reports 2014; 4(1) doi: 10.1038/srep07252
|
52 |
Dirk Graf, Daniel Vallböhmer, Wolfram Trudo Knoefel, Patric Kröpil, Gerald Antoch, Abdurrahaman Sagir, Dieter Häussinger. Multimodal treatment of hepatocellular carcinoma. European Journal of Internal Medicine 2014; 25(5): 430 doi: 10.1016/j.ejim.2014.03.001
|
53 |
Federica Invernizzi, Massimo Colombo. Pathway of Care of Hepatocellular Carcinoma in 2017. Hepatic Oncology 2016; 3(4): 217 doi: 10.2217/hep-2017-0004
|
54 |
Jennifer J. Knox, Sean P. Cleary, Laura A. Dawson. Localized and Systemic Approaches to Treating Hepatocellular Carcinoma. Journal of Clinical Oncology 2015; 33(16): 1835 doi: 10.1200/JCO.2014.60.1153
|
55 |
Jiping Wang, Yunju Im, Rong Wang, Shuangge Ma. Partial Hepatectomy and Ablation for Survival of Early-Stage Hepatocellular Carcinoma Patients: A Bayesian Emulation Analysis. Life 2024; 14(6): 661 doi: 10.3390/life14060661
|
56 |
Chih-Hao Lin, Cheng-Maw Ho, Chih-Horng Wu, Po-Chin Liang, Yao-Ming Wu, Rey-Heng Hu, Po-Huang Lee, Ming-Chih Ho. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis. Surgical Endoscopy 2020; 34(12): 5566 doi: 10.1007/s00464-019-07357-x
|
57 |
Luca Quagliata, Manuel Schlageter, Cristina Quintavalle, Luigi Tornillo, Luigi Terracciano. Identification of New Players in Hepatocarcinogenesis: Limits and Opportunities of Using Tissue Microarray (TMA). Microarrays 2014; 3(2): 91 doi: 10.3390/microarrays3020091
|
58 |
Pankaj Gupta, Naveen Kalra, Shyamkumar N. Keshava, Sreedhara B. Chaluvashetty, Amar Mukund, Shuvro H. Roy-Choudhury, Sanjay Saran Baijal, Anubhav Khandelwal, Venkatesh Hosur Ananthashayana, Sathya Narayanan R., Suyash Kulkarni, Nitin Sudhakar Shetty, Arun Gupta, Sanjay Gupta. Indian Society of Vascular and Interventional Radiology Expert Consensus Statements for Ablation in Hepatocellular Carcinoma: Part I. Journal of Clinical Interventional Radiology ISVIR 2020; 4(02): 098 doi: 10.1055/s-0040-1715774
|
59 |
Subrat K. Acharya. Treatment for Hepatocellular Carcinoma in South Asia. Journal of Clinical and Experimental Hepatology 2021; 11(6): 641 doi: 10.1016/j.jceh.2021.09.018
|
60 |
Zhang Zhong-yi, Yang Wei, Yan Kun, Dai Ying, Wu Wei, Lee Jung-chieh, Chen Min-hua. Needle track seeding after percutaneous radiofrequency ablation of hepatocellular carcinoma: 14-year experience at a single centre. International Journal of Hyperthermia 2017; 33(4): 454 doi: 10.1080/02656736.2017.1278630
|
61 |
Akiyoshi Kinoshita, Kazuhiko Koike, Hirokazu Nishino. Clinical features and prognosis of elderly patients with hepatocellular carcinoma not indicated for surgical resection. Geriatrics & Gerontology International 2017; 17(2): 189 doi: 10.1111/ggi.12747
|
62 |
Matteo Canale, Francesco Giuseppe Foschi, Pietro Andreone, Giorgio Ercolani, Giorgia Marisi, Fabio Conti, Ranka Vukotic, Valeria Guarneri, Valentina Burgio, Francesca Ratti, Luca Aldrighetti, Francesco De Cobelli, Stefano Cascinu, Paola Ulivi, Andrea Casadei-Gardini. Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery. HPB 2022; 24(2): 244 doi: 10.1016/j.hpb.2021.06.421
|
63 |
Hwaseong Ryu, Tae Un Kim, Jun Woo Lee, Ung Bae Jeon, Jin Hyeok Kim, Joo Yeon Jang, Ki Tae Yoon, Young Mi Hong. Factors associated with increased risk of peritoneal seeding after radiofrequency ablation for hepatocellular carcinoma. Abdominal Radiology 2023; 48(10): 3243 doi: 10.1007/s00261-023-03987-x
|